BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26472455)

  • 1. Stable Delivery of CCR5-Directed shRNA into Human Primary Peripheral Blood Mononuclear Cells and Hematopoietic Stem/Progenitor Cells via a Lentiviral Vector.
    Shimizu S; Yadav SS; An DS
    Methods Mol Biol; 2016; 1364():235-48. PubMed ID: 26472455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection.
    Anderson J; Akkina R
    Retrovirology; 2005 Aug; 2():53. PubMed ID: 16109172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors.
    Fish RJ; Kruithof EK
    BMC Mol Biol; 2004 Aug; 5():9. PubMed ID: 15291968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering HIV-1-resistant T-cells from short-hairpin RNA-expressing hematopoietic stem/progenitor cells in humanized BLT mice.
    Ringpis GE; Shimizu S; Arokium H; Camba-Colón J; Carroll MV; Cortado R; Xie Y; Kim PY; Sahakyan A; Lowe EL; Narukawa M; Kandarian FN; Burke BP; Symonds GP; An DS; Chen IS; Kamata M
    PLoS One; 2012; 7(12):e53492. PubMed ID: 23300932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
    Anderson J; Akkina R
    Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.
    Li MJ; Bauer G; Michienzi A; Yee JK; Lee NS; Kim J; Li S; Castanotto D; Zaia J; Rossi JJ
    Mol Ther; 2003 Aug; 8(2):196-206. PubMed ID: 12907142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preintegration HIV-1 inhibition by a combination lentiviral vector containing a chimeric TRIM5 alpha protein, a CCR5 shRNA, and a TAR decoy.
    Anderson JS; Javien J; Nolta JA; Bauer G
    Mol Ther; 2009 Dec; 17(12):2103-14. PubMed ID: 19690520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HIV-1 infection by a unique short hairpin RNA to chemokine receptor 5 delivered into macrophages through hematopoietic progenitor cell transduction.
    Liang M; Kamata M; Chen KN; Pariente N; An DS; Chen IS
    J Gene Med; 2010 Mar; 12(3):255-65. PubMed ID: 20186995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of GM-CSF receptor function by stable RNA interference in a NOD/SCID mouse hematopoietic stem cell transplantation model.
    Scherr M; Battmer K; Dallmann I; Ganser A; Eder M
    Oligonucleotides; 2003; 13(5):353-63. PubMed ID: 15000826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-transduction of lentiviral and adenoviral vectors for co-delivery of growth factor and shRNA genes in mesenchymal stem cells-based chondrogenic system.
    Zhang F; Yao Y; Su K; Fang Y; Citra F; Wang DA
    J Tissue Eng Regen Med; 2015 Sep; 9(9):1036-45. PubMed ID: 23193077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted transduction of CD34+ hematopoietic progenitor cells in nonpurified human mobilized peripheral blood mononuclear cells.
    Liang M; Pariente N; Morizono K; Chen IS
    J Gene Med; 2009 Mar; 11(3):185-96. PubMed ID: 19152374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.
    Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A
    Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression.
    Butticaz C; Ciuffi A; Muñoz M; Thomas J; Bridge A; Pebernard S; Iggo R; Meylan P; Telenti A
    Antivir Ther; 2003 Oct; 8(5):373-7. PubMed ID: 14640383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model.
    Shimizu S; Hong P; Arumugam B; Pokomo L; Boyer J; Koizumi N; Kittipongdaja P; Chen A; Bristol G; Galic Z; Zack JA; Yang O; Chen IS; Lee B; An DS
    Blood; 2010 Feb; 115(8):1534-44. PubMed ID: 20018916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral gene transfer into human and murine hematopoietic stem cells: size matters.
    Canté-Barrett K; Mendes RD; Smits WK; van Helsdingen-van Wijk YM; Pieters R; Meijerink JP
    BMC Res Notes; 2016 Jun; 9():312. PubMed ID: 27306375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.
    Li MJ; Kim J; Li S; Zaia J; Yee JK; Anderson J; Akkina R; Rossi JJ
    Mol Ther; 2005 Nov; 12(5):900-9. PubMed ID: 16115802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of short hairpin RNA for lentiviral-mediated RNAi against WAS.
    Jeanson-Leh L; Blondeau J; Galy A
    Biochem Biophys Res Commun; 2007 Oct; 362(2):498-503. PubMed ID: 17719003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors.
    An DS; Qin FX; Auyeung VC; Mao SH; Kung SK; Baltimore D; Chen IS
    Mol Ther; 2006 Oct; 14(4):494-504. PubMed ID: 16844419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-efficiency lentiviral transduction of primary human CD34⁺ hematopoietic cells with low-dose viral inocula.
    Park SW; Pyo CW; Choi SY
    Biotechnol Lett; 2015 Feb; 37(2):281-8. PubMed ID: 25257593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors.
    Sirven A; Ravet E; Charneau P; Zennou V; Coulombel L; Guétard D; Pflumio F; Dubart-Kupperschmitt A
    Mol Ther; 2001 Apr; 3(4):438-48. PubMed ID: 11319904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.